Scarica l'app Stockscreener
0.642
0.29%
-0.0047
Dopo l'orario di chiusura:
.64
-0.002
-0.31%
Precedente Chiudi:
$0.6467
Aprire:
$0.64
Volume 24 ore:
20,660
Relative Volume:
0.29
Capitalizzazione di mercato:
$18.56M
Reddito:
$1.08M
Utile/perdita netta:
$-20.06M
Rapporto P/E:
-0.3415
EPS:
-1.88
Flusso di cassa netto:
$-16.19M
1 W Prestazione:
-5.29%
1M Prestazione:
-48.83%
6M Prestazione:
-60.92%
1 anno Prestazione:
-63.36%
Intervallo 1D:
$0.64
$0.6831
Intervallo di 1 settimana:
$0.5946
$0.6997
Portata 52W:
$0.5946
$2.115
Cyclo Therapeutics Inc Stock (CYTH) Company Profile
Nome
Cyclo Therapeutics Inc
Settore
Telefono
386-418-8060
Indirizzo
6714 NW 16TH STREET, SUITE B, GAINESVILLE
Cyclo Therapeutics Inc Borsa (CYTH) Ultime notizie
Cyclo Therapeutics secures $3 million convertible note financing - Investing.com
Cyclo Therapeutics secures $3 million convertible note financing - Investing.com India
Cyclo Therapeutics secures $3 million convertible note financing By Investing.com - Investing.com UK
CYTH stock touches 52-week low at $0.68 amid market challenges - Investing.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - Morningstar
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - cnhinews.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (NasdaqCFB), Arch Resources, Inc. (NYSEARCH), Cyclo Therapeutics, Inc. (NasdaqCYTH), Vector Group Ltd. (NYSE - GlobeNewswire Inc.
CYTH stock touches 52-week low at $0.68 amid market challenges - Investing.com Canada
CYTH stock touches 52-week low at $0.68 amid market challenges - Investing.com UK
Cyclo Therapeutics reports progress in NPC treatment trials - Investing.com India
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) - StockTitan
Cyclo Therapeutics Inc (CYTH) deserves deeper analysis - US Post News
What is Cyclo Therapeutics Inc (CYTH) Stock Return on Shareholders’ Capital? - SETE News
CYTH stock touches 52-week low at $0.77 amid market challenges - Investing.com
Shareholder Alert: Ademi LLP investigates whether ARC Document Solutions, Inc. has obtained a Fair Price for its Public Shareholders - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, ARCH, CYTH on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, ARCH, CYTH on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq – CFB), Arch Resources, Inc. (NYSE – ARCH), Cyclo Therapeutics, Inc. (Nasdaq – CYTH), Vector Group Ltd. (NYSE – VG - ForexTV.com
This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday - Benzinga
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Marketscreener.com
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders - Morningstar
Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, YOTTA, PLMJ on Behalf of Shareholders - Longview News-Journal
Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders - ForexTV.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders - GlobeNewswire Inc.
Cyclo Therapeutics stock downgraded as acquisition loomsH.C. Wainwright - Investing.com
Niemann-Pick Disease Type C Market Forecasted to Surge in Coming - openPR
Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Cyclo Therapeutics, Inc. has obtained a Fair Price for its Public Shareholders - PR Newswire
KISS Celebrates 35 Years of Beauty Innovation - The Bubble
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc.CYTH - PR Newswire
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers of VGR, CYTH - AccessWire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - AccessWire
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results - Benzinga
CYTH Stock Touches 52-Week Low at $0.88 Amid Market Challenges - Investing.com India
Rafael Holdings and Cyclo Therapeutics announce merger - Investing.com
Gold Down Over 1%; US Initial Jobless Claims Increase - Benzinga
RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders - Business Wire
CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders - Winchester Herald Chronicle
CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement - ForexTV.com
Rafael Holdings Announces Strategic Merger with Cyclo Therapeutics - TipRanks
Cyclo Therapeutics’ Merger and Financial Arrangements with Rafael Holdings - TipRanks
Rafael Holdings and Cyclo Therapeutics To Merge - citybiz
Rafael Holdings and Cyclo Therapeutics announce merger - Investing.com India
Cyclo Therapeutics Inc Azioni (CYTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
0.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):